دورية أكاديمية
أعرض في EDS

Assessing Substance Use Disorder Symptoms with a Checklist among Primary Care Patients with Opioid Use Disorder and/or Long-Term Opioid Treatment: An Observational Study.

التفاصيل البيبلوغرافية
العنوان: Assessing Substance Use Disorder Symptoms with a Checklist among Primary Care Patients with Opioid Use Disorder and/or Long-Term Opioid Treatment: An Observational Study.
المؤلفون: Williams EC; Department of Health Systems and Population Health, University of Washington School of Public Health, The Hans Rosling Building, Floor 4, Seattle, WA, 98195, USA. emwilli@uw.edu.; Health Services Research & Development (HSR&D) Center for Innovation for Veteran-Centered and Value- Driven Care, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, WA, 98101, USA. emwilli@uw.edu.; Kaiser Permanente Washington Health Research Institute, Seattle, WA, 98101, USA. emwilli@uw.edu., Matson TE; Department of Health Systems and Population Health, University of Washington School of Public Health, The Hans Rosling Building, Floor 4, Seattle, WA, 98195, USA.; Health Services Research & Development (HSR&D) Center for Innovation for Veteran-Centered and Value- Driven Care, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, WA, 98101, USA.; Kaiser Permanente Washington Health Research Institute, Seattle, WA, 98101, USA., Hallgren KA; Department of Health Systems and Population Health, University of Washington School of Public Health, The Hans Rosling Building, Floor 4, Seattle, WA, 98195, USA.; Kaiser Permanente Washington Health Research Institute, Seattle, WA, 98101, USA.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, 98195, USA., Oliver M; Kaiser Permanente Washington Health Research Institute, Seattle, WA, 98101, USA., Wang X; National Institute On Drug Abuse, Clinical Trials Network, Bethesda, MD, USA., Bradley KA; Department of Health Systems and Population Health, University of Washington School of Public Health, The Hans Rosling Building, Floor 4, Seattle, WA, 98195, USA.; Kaiser Permanente Washington Health Research Institute, Seattle, WA, 98101, USA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA, 98195, USA.
المصدر: Journal of general internal medicine [J Gen Intern Med] 2024 Sep; Vol. 39 (12), pp. 2169-2178. Date of Electronic Publication: 2024 Jul 01.
نوع المنشور: Journal Article; Observational Study
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8605834 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1497 (Electronic) Linking ISSN: 08848734 NLM ISO Abbreviation: J Gen Intern Med Subsets: MEDLINE
أسماء مطبوعة: Publication: Secaucus, NJ : Springer
Original Publication: [Philadelphia, PA] : Hanley & Belfus, [c1986-
مواضيع طبية MeSH: Checklist* , Opioid-Related Disorders*/diagnosis , Primary Health Care*, Humans ; Male ; Female ; Middle Aged ; Adult ; Analgesics, Opioid/therapeutic use ; Aged ; Young Adult ; Psychometrics ; Opiate Substitution Treatment ; Substance-Related Disorders/diagnosis ; Substance-Related Disorders/epidemiology
مستخلص: Background: Primary care (PC) offers an opportunity to treat opioid use disorders (OUD). The Substance Use Symptom Checklist ("Checklist") can assess DSM-5 substance use disorder (SUD) symptoms in PC.
Objective: To test the psychometric properties of the Checklist among PC patients with OUD or long-term opioid therapy (LTOT) in Kaiser Permanente Washington (KPWA).
Design: Observational study using item response theory (IRT) and differential item functioning (DIF) analyses of measurement consistency across age, sex, race and ethnicity, and receipt of treatment.
Patients: Electronic health records (EHR) data were extracted for all adult PC patients visiting KPWA 3/1/15-8/30/2020 who had ≥ 1 Checklist documented and indication of either (a) clinically-recognized OUD (i.e., documented OUD diagnosis and/or OUD medication treatment) or (b) LTOT in the year prior to the checklist.
Main Measure: The Checklist includes 11 items reflecting DSM-5 criteria for SUD. We described the prevalence of 2 SUD symptoms reported on the Checklist (consistent with mild-severe DSM-5 SUD). Analyses were conducted in the overall sample and in two subsamples (clinically-recognized OUD and LTOT only).
Key Results: Among 2007 eligible patients, 39.9% endorsed ≥ 2 SUD symptoms (74.3% in the clinically-recognized OUD subsample and 13.1% in LTOT subsample). IRT indicated that a unidimensional model for the 11 checklist items had excellent fit (comparative fit index = 0.998) with high item-level discrimination parameters for the overall sample and both subsamples. DIF across age, race and ethnicity, and treatment was observed for one item each, but had minimal impact on expected number of criteria (0-11) patients endorse.
Conclusions: The Substance Use Symptom Checklist measured SUD symptoms consistent with DSM-5 conceptualization (scaled, unidimensional) in patients with clinically-recognized OUD and LTOT and had similar measurement properties across demographic subgroups. The Checklist may support symptom assessment in patients with OUD and diagnosis in patients with LTOT.
(© 2024. The Author(s), under exclusive licence to Society of General Internal Medicine.)
References: Subst Abus. 2021;42(1):116-122. (PMID: 31860380)
J Behav Health Serv Res. 2023 Jan;50(1):108-118. (PMID: 35948799)
J Public Health Manag Pract. 2020 May/Jun;26(3):206-213. (PMID: 31441793)
Addiction. 2019 Aug;114(8):1355-1356. (PMID: 31037777)
J Addict Med. 2023 Jul-Aug 01;17(4):471-473. (PMID: 37579113)
JAMA Netw Open. 2022 Nov 1;5(11):e2239772. (PMID: 36318205)
Subst Abus. 2022;43(1):564-572. (PMID: 34586976)
JAMA Psychiatry. 2019 Feb 1;76(2):208-216. (PMID: 30516809)
JAMA Intern Med. 2023 Apr 1;183(4):319-328. (PMID: 36848119)
JAMA Netw Open. 2023 Aug 1;6(8):e2328627. (PMID: 37566414)
Addict Sci Clin Pract. 2012 Aug 28;7:17. (PMID: 23186354)
J Gen Intern Med. 2023 Feb;38(2):332-340. (PMID: 35614169)
Subst Abus. 2022;43(1):1043-1050. (PMID: 35467489)
J Gen Intern Med. 2022 Jun;37(8):1885-1893. (PMID: 34398395)
Ann Intern Med. 2016 Nov 15;165(10):690-699. (PMID: 27595276)
Drug Alcohol Depend. 2019 Aug 1;201:134-141. (PMID: 31212213)
J Gen Intern Med. 2018 Mar;33(3):258-267. (PMID: 29086341)
J Subst Abuse Treat. 2020 Mar;110:18-27. (PMID: 31952624)
Psychol Med. 2006 Jul;36(7):931-41. (PMID: 16563205)
Patient. 2014;7(1):23-35. (PMID: 24403095)
JAMA Netw Open. 2022 Jun 1;5(6):e2219651. (PMID: 35771574)
Drug Alcohol Depend. 2020 Feb 1;207:107732. (PMID: 31835068)
Implement Sci. 2018 Aug 6;13(1):108. (PMID: 30081930)
BMC Health Serv Res. 2019 Nov 25;19(1):884. (PMID: 31767011)
Drug Alcohol Depend. 2021 Aug 1;225:108791. (PMID: 34098384)
JAMA Netw Open. 2023 May 1;6(5):e2316283. (PMID: 37234003)
Alcohol Clin Exp Res. 2013 Aug;37(8):1380-90. (PMID: 23906469)
BMJ. 2021 May 19;373:n784. (PMID: 34011512)
J Gen Intern Med. 2020 Apr;35(4):1111-1119. (PMID: 31974903)
Arch Intern Med. 2010 Jul 12;170(13):1155-60. (PMID: 20625025)
Drug Alcohol Depend. 2013 Sep 1;132(1-2):352-61. (PMID: 23561823)
Addiction. 2019 Aug;114(8):1346-1353. (PMID: 30614096)
Addict Sci Clin Pract. 2018 Apr 9;13(1):8. (PMID: 29628018)
Ann Intern Med. 2017 Feb 21;166(4):268-278. (PMID: 27919103)
Int J Psychiatry Med. 2021 Jan;56(1):14-39. (PMID: 32726568)
معلومات مُعتمدة: UG1 DA040314 United States DA NIDA NIH HHS; UG1DA040314 National Drug Abuse Treatment Clinical Trials Network
فهرسة مساهمة: Keywords: opioid use disorder; opioids; substance use disorder; symptom assessment
المشرفين على المادة: 0 (Analgesics, Opioid)
تواريخ الأحداث: Date Created: 20240702 Date Completed: 20240826 Latest Revision: 20240830
رمز التحديث: 20240830
مُعرف محوري في PubMed: PMC11347511
DOI: 10.1007/s11606-024-08845-0
PMID: 38954321
قاعدة البيانات: MEDLINE
الوصف
تدمد:1525-1497
DOI:10.1007/s11606-024-08845-0